# Genetically Modified Lymphocytes to Treat HIV-Infected Identical Twins - Study Modifications

> **NCT00001409** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 100 (—)

## Conditions studied

- Acquired Immunodeficiency Syndrome
- HIV Infection

## Interventions

- **DRUG:** Interleukin-2

## Key facts

- **NCT ID:** NCT00001409
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1994-09
- **Primary completion:** —
- **Final completion:** 2002-06
- **Target enrollment:** 100 (—)
- **Last updated:** 2008-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00001409

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00001409, "Genetically Modified Lymphocytes to Treat HIV-Infected Identical Twins - Study Modifications". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00001409. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*